Prostate Cancer

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: A Phase 2/3,PSMA-T4, Prostate Cancer [NA]

  A Phase 2/3 clinical trial update investigating PSMA-T4 for prostate cancer is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer [Phase 2]

  Phase 2 trial evaluating M1774 in hard-to-treat prostate cancer is currently active but not recruiting. The study targets castration-resista…

• CLINICAL_TRIALS trial_result · 2026-04-14
  Clinical Trial Update: A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer [NA]

  Trial update for a meaning-centered therapy study in Mexican adults with advanced cancer; the study is currently not recruiting.

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study

  This clinical trial registry entry describes the BALANCE Study, a PROMS study exploring the lived experiences of Black and mixed-race men wi…

• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation [NA]

  A clinical trial update describes a study evaluating peer navigation to support metastatic prostate cancer patients undergoing genetic evalu…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-04-14
  Clinical Trial Update: Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer [Phase 3]

  A Phase 3 clinical trial assessing the diagnostic performance of the radiotracer [18F]PSMA-1007 PET/CT for newly diagnosed prostate cancer.

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Radium-223 in Combination With Enzalutamide [Phase 2]

  A Phase 2 clinical trial evaluating Radium-223 in combination with enzalutamide for prostate cancer has completed.

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Neo-adjuvant Abiraterone Prostate Study [Phase 2]

  A Phase 2 neoadjuvant trial evaluating abiraterone in high-risk localized prostate cancer has completed.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer [Phase 3]

  A Phase 3 clinical trial is investigating adding apalutamide to radiotherapy and LHRH agonist in high-risk hormone-sensitive prostate cancer…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection [NA]

  This clinical trial update reports on the diagnostic performance of high-resolution specimen PET-CT for determining margin status during can…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: AASUR in High Risk Prostate Cancer [Phase 2]

  Phase 2 clinical trial update for AASUR in high-risk prostate cancer. The study is completed and results were posted on 2026-04-13.

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer [Phase 2]

  This document reports a Phase II trial evaluating pencil beam scanning proton stereotactic body radiation therapy for prostate cancer.

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer [Phase 1]

  A Phase 1 clinical trial update evaluating the effect of multiple doses of JNJ-56021927 on the pharmacokinetics of various cytochrome P450 s…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer [Phase 1]

  This clinical trial update describes a Phase 1 study evaluating the combination of JNJ-78278343 and JNJ-95298177 for prostate cancer, with t…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones [Phase 1]

  Phase 1 safety study of Sn-117m-DTPA for cancers that have spread to bone, including metastatic breast, lung, and prostate cancers; the tria…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study [Phase 2]

  Phase 2 clinical trial for prostate cancer patients who previously participated in an enzalutamide study; the study is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer [NA]

  This entry notes a clinical trial evaluating concomitant trans-perineal prostate biopsy and ablation (Bioblation) for prostate cancer, curre…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

  The study on biospecimen collection to identify genetic changes in patients with various cancers undergoing surgery is currently suspended; …

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer [Phase 1, Phase 2]

  A Phase 1/2 clinical trial is evaluating sequencing abemaciclib before 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer, w…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer [Phase 1]

  Phase 1 study of JNJ-69086420, an Actinium-225-labeled antibody targeting hK2, for advanced prostate cancer is currently active but not recr…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer [Phase 1]

  Phase 1 trial update on MK-2206 plus hydroxychloroquine for advanced solid tumors, including melanoma, prostate cancer, and renal cell carci…

• CLINICAL_TRIALS other · 2026-04-13
  Clinical Trial Update: POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions [Phase 2]

  Phase 2 clinical trial update on POSLUMA (18F-rhPSMA-7.3) PET-CT for evaluating PIRADS 2/3 lesions in prostate cancer; the study is currentl…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection [Phase 1, Phase 2]

  A phase 1/2 clinical trial evaluating anti-tumor activity of (177Lu) rhPSMA-10.1 injection in prostate cancer, including metastatic castrati…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer [Phase 1]

  This clinical trial update describes a Phase 1 study of ARX517/JNJ-95298177 as monotherapy or in combination for metastatic prostate cancer.…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma [Phase 1]

  Phase 1 clinical trial update on QXL138AM assessing safety, pharmacokinetics, and preliminary efficacy in patients with solid tumors and mul…